Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosis

被引:41
作者
Oliva, J [1 ]
Moreno, S
Sanz, J
Ribera, E
Molina, JAOP
Rubio, R
Casas, E
Mariño, A
机构
[1] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[2] Hosp Princesa, Madrid, Spain
[3] Hosp Gen Valle Hebron, Barcelona, Spain
[4] Hosp Gen Gregorio Maranon, Madrid, Spain
[5] Hosp Doce Octubre, Madrid, Spain
[6] Hosp Principe Asturias, Alcala De Henares, Spain
[7] Hosp Arquitecto Marcide, El Ferrol, Spain
关键词
D O I
10.1097/00002030-200303070-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:637 / 638
页数:2
相关论文
共 9 条
[1]  
*CDCP, 1998, MMWR-MORBID MORTAL W, V47, P36
[2]   Effect of tuberculosis therapy on nevirapine trough plasma concentrations [J].
Dean, GL ;
Back, DJ ;
de Ruiter, A .
AIDS, 1999, 13 (17) :2489-2490
[3]   HIGH-DOSE NEVIRAPINE - SAFETY, PHARMACOKINETICS, AND ANTIVIRAL EFFECT IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
HAVLIR, D ;
CHEESEMAN, SH ;
MCLAUGHLIN, M ;
MURPHY, R ;
ERICE, A ;
SPECTOR, SA ;
GREENOUGH, TC ;
SULLIVAN, JL ;
HALL, D ;
MYERS, M ;
LAMSON, M ;
RICHMAN, DD .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :537-545
[4]  
LOPEZCORTES LF, 2001, 8 C RETR OPP INF CHI
[5]   Treatment of tuberculosis in HIV-infected patients:: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin [J].
Moreno, S ;
Podzamczer, D ;
Blázquez, R ;
Iribarren, JA ;
Ferrer, E ;
Reparaz, J ;
Peña, JM ;
Cabrero, E ;
Usán, L .
AIDS, 2001, 15 (09) :1185-1187
[6]  
Ribera E, 2001, J ACQ IMMUN DEF SYND, V28, P450, DOI 10.1097/00042560-200112150-00007
[7]  
ROBINSON P, 1998, 12 INT C AIDS GEN SW
[8]   Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons [J].
Sterling, TR ;
Alwood, K ;
Gachuhi, R ;
Coggin, W ;
Blazes, D ;
Bishai, WR ;
Chaisson, RE .
AIDS, 1999, 13 (14) :1899-1904
[9]   Ritonavir enables combined therapy with rifampin and saquinavir [J].
Veldkamp, AI ;
Hoetelmans, RMW ;
Beijnen, JH ;
Mulder, JW ;
Meenhorst, PL .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) :1586-1586